Latest News
☰
×
Home
Education
Chronic Kidney Disease and Acid
Chronic Kidney Disease and Anemia
Chronic Kidney Disease and Diabetes
Chronic Kidney Disease and Healthy Bones
Chronic Kidney Disease and Hypertension
Chronic Kidney Disease and Nutrition
Chronic Kidney Disease and Protein
Chronic Kidney Disease and Vitamin D
RSH Smoking Guide
Top 10 Tips for Chronic Kidney Disease Patients
Services
About Us
Contact Us
Blog
By
Galen Care Partners
on Wednesday, 12 April 2017
Category:
Galen Care Partners News
Tolvaptan Offers Sustained Slowing of Renal Function Decline in ADPKD
Open-label extension study confirms disease-modifying effect on eGFR, but not total kidney volume growth.
Original link
Leave Comments